Check this out.. Reassuring for NEPT as well as their 57% owned subsidiary, APO.V http://www.thelifesciencesreport.com/pub/na/14746?utm_source=delivra&utm_medium=email&utm_campaign=The+Life+Sciences+Report+11-15-12